April 1985
Volume 26, Issue 4
Articles  |   April 1985
Retinal S-antigen and retinoblastoma: a monoclonal antibody and flow cytometric study.
Investigative Ophthalmology & Visual Science April 1985, Vol.26, 568-571. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L A Donoso, N T Felberg, J J Augsburger, J A Shields; Retinal S-antigen and retinoblastoma: a monoclonal antibody and flow cytometric study.. Invest. Ophthalmol. Vis. Sci. 1985;26(4):568-571.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Retinal S-antigen was demonstrated in the WERI-Rb1 and to a lesser extent the Y-79 tissue cultured retinoblastoma cell lines as well as an ethanol-fixed, paraffin-embedded retinoblastoma by an indirect immunoperoxidase technique using monoclonal antibody MAbA9-C6, and by flow cytometric analysis (FCM) using MAbA9-C6 and MAbA1-G5. In fixed tissue sections, S-antigen immunoreactivity was restricted and localized to small numbers of retinoblastoma cells, including Flexner-Wintersteiner rosettes. By FCM, MAbA9-C6 bound to 15.4% of WERI-Rb1 cells and to 10.99.7% of Y-79 cells whereas MAbA1-G5 bound to 14.66% of WERI-Rb1 and to 4.23% of Y-79 cells respectively. Cell cycle analysis showed that S-antigen was predominately expressed in the resting (G0/G1) phase. The usefulness of MAbA9-C6 in studying the embryological development of the retina and as a marker protein for studying antigenic expression and modulation in retinoblastomas is discussed.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.